Bendamustine for patients with indolent B cell lymphoid malignancies including chronic lymphocytic leukaemia

Overview of attention for article published in Cochrane database of systematic reviews, September 2012

Altmetric Badge

Mentioned by

twitter: 1 X user

facebook: 1 Facebook page

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 117 Mendeley

Summary X Facebook Dimensions citations

So far, Dimensions has found 12 publications that cite this research output.

12

The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.

Real Life Use of Bendamustine in Elderly Patients with Lymphoid Neoplasia

Article in Journal of Personalized Medicine (March 2021)

Mitigating the risk of cytokine release syndrome in a Phase I trial of CD20/CD3 bispecific antibody mosunetuzumab in NHL: impact of translational system modeling

Article in npj Systems Biology and Applications (August 2020)

Bendamustine for patients with indolent B cell lymphoproliferative malignancies including chronic lymphocytic leukaemia – an updated meta‐analysis

Article in British Journal of Haematology (April 2019)